Literature DB >> 15198166

Optimizing medication adherence in older persons with hypertension.

William J Elliott1.   

Abstract

Suboptimal control of hypertension in large communities can be attributed, in part, to about 50% of patients who stop taking their antihypertensive drugs after 1 year. Older patients with many illnesses (including chronic kidney disease) are at especially high risk for discontinuing prescribed medications, but age is a weaker predictor than the number of consumed pills. Determining if medications are being taken as prescribed is difficult, but asking the patient and significant other the simple question, "Have you missed any pills in the last week?" is a good place to start. Despite all their other virtues, clinical trials seldom provide the same answers regarding medication adherence that are found in clinical practice. Observational and a few interventional trials have established that short, simple regimens that improve patients' symptoms and are well tolerated are more likely to be taken correctly. Patient (and family) education is the cornerstone of improving adherence to medication, but several other interventions have also proven useful. There appears to be no "magic bullet" that will improve medication adherence in all patients, but providing written instructions, simplifying the medication regimen to as few as necessary, once daily, well tolerated and inexpensive pills, involving family members, and prompting pill taking by certain activities of daily living all seem to help. Improving medication adherence would be a simple way to make antihypertensive therapies much more cost effective, since a medication that is not taken incurs all of cost, and provides no benefit to the patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15198166     DOI: 10.1023/b:urol.0000025643.80319.b3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  25 in total

Review 1.  How well is hypertension controlled in Europe?

Authors:  S Erdine
Journal:  J Hypertens       Date:  2000-09       Impact factor: 4.844

2.  Compliance--and improving it--in hypertension.

Authors:  William J Elliott
Journal:  Manag Care       Date:  2003-08

3.  Inadequate management of blood pressure in a hypertensive population.

Authors:  D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

4.  Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.

Authors:  J J Caro; J L Speckman; M Salas; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

5.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

6.  Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance?

Authors:  J Mar; F Rodríguez-Artalejo
Journal:  J Hypertens       Date:  2001-01       Impact factor: 4.844

7.  Variations in compliance among hypertensive patients by drug class: implications for health care costs.

Authors:  J A Rizzo; W R Simons
Journal:  Clin Ther       Date:  1997 Nov-Dec       Impact factor: 3.393

8.  Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. Systolic Hypertension in the Elderly Program.

Authors:  D M Black; R J Brand; M Greenlick; G Hughes; J Smith
Journal:  J Gerontol       Date:  1987-09

9.  Improving blood pressure control in a pharmacist-managed hypertension clinic.

Authors:  Eva M Vivian
Journal:  Pharmacotherapy       Date:  2002-12       Impact factor: 4.705

Review 10.  Medication compliance in the elderly.

Authors:  C Salzman
Journal:  J Clin Psychiatry       Date:  1995       Impact factor: 4.384

View more
  4 in total

1.  An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures.

Authors:  Jacqueline A Pesa; Jill Van Den Bos; Travis Gray; Colleen Hartsig; Robert Brett McQueen; Joseph J Saseen; Kavita V Nair
Journal:  Patient Prefer Adherence       Date:  2012-01-18       Impact factor: 2.711

Review 2.  Preventing coronary heart disease risk of slum dwelling residents in India.

Authors:  Lipi Dhar
Journal:  J Family Med Prim Care       Date:  2014-01

3.  Effect of a formalised discharge process which includes electronic delivery of prescriptions to pharmacies on the incidence of delayed prescription retrieval.

Authors:  Ayaaz Kazmir Sachedina; Sonia Mota; Julie Lorenzin; Marlene Allegretti; Maureen Leyser; Alan Gob; Robert McKelvie
Journal:  BMJ Open Qual       Date:  2020-05

4.  Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies.

Authors:  Timothy R Smith; Thomas Philipp; Bernard Vaisse; George L Bakris; Margaret Wernsing; Joseph Yen; Robert Glazer
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-05       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.